Francisco Javier Lavilla Royo-rekin lankidetzan egindako argitalpenak (6)

2020

  1. Burden and challenges of heart failure in patients with chronic kidney disease. A call to action

    Nefrologia, Vol. 40, Núm. 3, pp. 223-236

2019

  1. Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?

    American Journal of Hypertension

2013

  1. Eficacia de tolvaptán en pacientes ingresados por insuficiencia cardiaca e hiponatremia refractaria. Experiencia en la práctica clínica diaria

    Revista Espanola de Cardiologia

  2. Renal autotransplant for subsequent endovascular exclusion of the thoracoabdominal aorta

    Annals of Vascular Surgery, Vol. 27, Núm. 7, pp. 974.e1-974.e6

2002

  1. Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 401-402

  2. Reduction in blood cyclosporine concentration by Orlistat in two renal transplant patients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 137-139